Trial
NCT00370942
GW823093C For The Treatment Of Type 2 Diabetes Mellitus
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
GW823093C A
Why stopped
Safety issue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-31